These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4161435)

  • 21. Evaulation of the potency of antipertussis serum products.
    Pittman M; Gardner RA; Marshall JF
    J Biol Stand; 1979 Jul; 7(3):263-273. PubMed ID: 227908
    [No Abstract]   [Full Text] [Related]  

  • 22. Comment on: Seroprevalence of Bordetella pertussis antibody in pregnant women in Iran.
    Sedighi I; Sadrosadat T
    J Res Health Sci; 2014; 14(3):236-7. PubMed ID: 25209914
    [No Abstract]   [Full Text] [Related]  

  • 23. Glycerol-releasing activity of histamine-sensitizing factor of Bordetella pertussis for rat adipocytes in vitro.
    Endoh M; Nakase Y
    Microbiol Immunol; 1982; 26(8):689-703. PubMed ID: 6294484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the histamine-sensitizing factor of Bordetella pertussis by density gradient centrifugation.
    Griffiths BW; Mason MA
    Can J Microbiol; 1968 May; 14(5):525-8. PubMed ID: 4173097
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunologic and biochemical properties of the histamine-sensitizing factor from Bordetella pertussis.
    Lehrer SB; Vaughan JH; Tan EM
    J Immunol; 1975 Jan; 114(1 Pt 1):34-9. PubMed ID: 46244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific and nonspecific passive desensitization. IX. The effect of diluting sensitizing doses of antiserum with normal heterologous and homologous sera.
    Swineford O
    Ann Allergy; 1967 Mar; 25(3):165-9. PubMed ID: 6020199
    [No Abstract]   [Full Text] [Related]  

  • 27. The effects of humoral, cellular and non-specific immunity on intracerebral Bordetella pertussis infections in mice.
    Dolby JM; Dolby DE; Bronne-Shanbury CJ
    J Hyg (Lond); 1975 Feb; 74(1):85-102. PubMed ID: 163275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-specific passive desensitization XX-XIV.
    Swineford O; Tinsley AL
    Ann Allergy; 1972 Mar; 30(3):126-34. PubMed ID: 4110914
    [No Abstract]   [Full Text] [Related]  

  • 29. [Antipertussis gamma globulins. IV. Isolation of immunoglobulins from mouse blood].
    Mitrică N; Andreescu V; Sorocinski F; Georgescu C; Caffé I; Marion M
    Arch Roum Pathol Exp Microbiol; 1970 Sep; 29(3):471-6. PubMed ID: 4106079
    [No Abstract]   [Full Text] [Related]  

  • 30. Specificity of Bordetella endotoxins in bactericidal systems.
    Pusztai Z; Csizér Z; Joó I
    Ann Immunol Hung; 1973; 17():suppl 59-61. PubMed ID: 4376904
    [No Abstract]   [Full Text] [Related]  

  • 31. Fixation and sensitizing capacity in the guinea pig of horse IgA, rabbit and chicken IgG.
    Kávai M; Csaba B; Kesztyüs L
    Acta Microbiol Acad Sci Hung; 1968; 15(2):111-7. PubMed ID: 4175989
    [No Abstract]   [Full Text] [Related]  

  • 32. A new method for the measurement of the opsonin titres of antisera to Bordetella pertussis.
    Holt LB
    J Biol Stand; 1975; 3(2):139-44. PubMed ID: 47859
    [No Abstract]   [Full Text] [Related]  

  • 33. Specific suppression of cell-mediated immune responses.
    Rowley DA; Fitch FW; Saitoh T; Stuart FP
    Transplant Proc; 1969 Mar; 1(1):580-2. PubMed ID: 4332533
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunological aspects of asthma.
    Amos HE
    Postgrad Med J; 1971 Mar; 47(545):166-70. PubMed ID: 4102666
    [No Abstract]   [Full Text] [Related]  

  • 35. Bordetella adenylate cyclase: a genus specific protective antigen and virulence factor.
    Novotny P; Chubb AP; Cownley K; Montaraz JA; Beesley JE
    Dev Biol Stand; 1985; 61():27-41. PubMed ID: 2872113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Passive protection with homologous antiserum against Trichostronglyus colubriformis in the guinea-pig.
    Connan RM
    Immunology; 1972 Oct; 23(4):647-50. PubMed ID: 5084105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of vaccines against pertussis caused by Bordetella holmesii using a mouse intranasal challenge model.
    Saito M; Odanaka K; Otsuka N; Kamachi K; Watanabe M
    Microbiol Immunol; 2016 Sep; 60(9):599-608. PubMed ID: 27515393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of disodium cromoglycate on various types of anaphylactic reaction in the guinea pig.
    Taylor WA; Roitt IM
    Int Arch Allergy Appl Immunol; 1973; 45(6):795-807. PubMed ID: 4128404
    [No Abstract]   [Full Text] [Related]  

  • 39. Passive protection of mice against intracerebral infections with Bordetella pertussis.
    Dolby JM
    J Hyg (Lond); 1972 Dec; 70(4):707-18. PubMed ID: 4346011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A model for experimental asthma: provocation in guinea-pigs immunized with Bordetella pertussis.
    Vertes C; Gonczy S; Lendvay N; Debreczeni LA
    Bull Eur Physiopathol Respir; 1987; 23 Suppl 10():111s-113s. PubMed ID: 2889487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.